Trial Profile
Safety and efficacy study of combination of capecitabine and oxaliplatin as an adjuvant chemotherapy in patients with stage II/III colon cancer: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Oct 2016 New trial record